Cite
HARVARD Citation
Straka, C. et al. (n.d.). Granulocyte-colony stimulating factor response is superior to neutropenia duration in predicting the risk of infection after high-dose chemotherapy for myeloma and lymphoma. Leukemia & lymphoma. 56 (2), pp. 368-376. [Online].